Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Yttrium 90 therapy |
Direct substance |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium (90-Y) chloride (substance) |
Is a |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|
Yttrium 90 brachytherapy |
Direct substance |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium-90 microspheres |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|
Product containing yttrium-90 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium[90Y] silicate injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|
Yttrium (90-Y) silicate (substance) |
Is a |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|
Yttrium 90 somatostatin analog therapy (procedure) |
Direct substance |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
2 |
Yttrium 90 somatostatin analog therapy (procedure) |
Using substance (attribute) |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium 90 somatostatin analog therapy (procedure) |
Using substance (attribute) |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Trans-arterial hepatic radioembolization using yttrium-90 microspheres (procedure) |
Using substance (attribute) |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium 90 brachytherapy |
Using substance (attribute) |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium 90 therapy |
Using substance (attribute) |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium 90 somatostatin analog therapy (procedure) |
Using substance (attribute) |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Trans-arterial hepatic radioembolization using yttrium-90 microspheres (procedure) |
Using substance (attribute) |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium 90 therapy |
Using substance (attribute) |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium 90 brachytherapy |
Using substance (attribute) |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Positron emission tomography with computed tomography of liver using yttrium 90 microspheres |
Using substance (attribute) |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
3 |
Radionuclide imaging using yttrium (90-Y) labeled somatostatin analog (procedure) |
Using substance (attribute) |
False |
Yttrium-90 (substance) |
Inferred relationship |
Some |
2 |
Yttrium (90-Y) labeled microspheres (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|
Yttrium (90-Y) silicate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|
Yttrium (90-Y) chloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|
Yttrium (90-Y) labeled somatostatin analog (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|
Product containing yttrium-90 in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium-90 only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium-90 only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
1 |
Yttrium 90 brachytherapy |
Using substance (attribute) |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
2 |
Yttrium (90-Y) citrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Yttrium-90 (substance) |
Inferred relationship |
Some |
|